Classes
DEA Class; Rx
Common Brand Names; Vaseretic
- ACEI/Diuretic Combos;
- ACEI/HCTZ Combos
Description
ACE inhibitor and thiazide diuretic; additive efficacy in HTN; given once or twice daily; counters the potassium loss from HCTZ; more effective than ACE monotherapy in black patients.
Indications
Indicated for the treatment of hypertension.
Contraindications
Hypersensitivity to ACE inhibitors, thiazides or sulfonamides
ACE-inibitor induced angioedema, hereditary or idiopathic angioedema
Coadministration of neprilysin inhibitors (eg, sacubitril) with ACE inhibitors may increase angioedema risk; do not administer ACE inhibitors within 36 hr of switching to or from sacubitril/valsartan
Renal stenosis or anuria
Do not coadminister with aliskiren in patients with diabetes
Adverse Effects
Enalapril
Dizziness (4-8%)
Hypotension (0.9-6.7%)
Headache (2-5%)
Chest pain (2%)
Cough (1-2%)
Rash (1.5%)
Hydrochlorothiazide
Hypotension
Anorexia
Epigastric distress
Hypokalemia
Phototoxicity
Warnings
Begin combination therapy only after failed monotherapy
Severe renal impairment, hepatic impairment
Risk of hypotension, especially in CHF patients
Dual blockade of the renin angiotensin system with ARBs, ACE inhibitors, or aliskiren associated with increased risk for hypotension, hyperkalemia, and renal function changes (including acute renal failure) compared to monotherapy
Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with angiotensin-converting enzyme inhibitors
If laryngeal stridor or angioedema of the face, tongue, or glottis occurs discontinue therapy and institute appropriate therapy immediately
Patients receiving coadministration of ACE inhibitor and mTOR (mammalian target of rapamycin) inhibitor (e.g. temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema
Intestinal angioedema has been reported in patients treated with ACE inhibitors
Cholestatic jaundice may occur, which may progress to fulminant hepatic necrosis; discontinue
Dry hacking nonproductive cough may occur within few months of treatment; consider other causes of cough prior to discontinuation
Hyperkalemia may occur with ACE inhibitors; risk factors include renal dysfunction, diabetes mellitus, and concomitant use of potassium sparing diuretics and potassium supplements; use cautiously if at all with these agents
Thiazide diuretics may cause hypokalemia, hypochloremic alkalosis, hypomagnesemia, and hyponatremia
Pregnancy and Lactation
Pregnancy Category: C (1st trimester); D (2nd and 3rd trimesters)
Lactation: Enters breast milk/not recommended
Maximum Dosage
20 mg/day PO enalapril and 50 mg/day PO hydrochlorothiazide.
20 mg/day PO enalapril and 50 mg/day PO hydrochlorothiazide.
Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Enalapril/hydrochlorothiazide
tablet
- 5mg/12.5mg
- 10mg/12.5mg